Skip to content
Search

Latest Stories

Study reveals flawed research on moderate alcohol health benefits

New findings challenge the long-held belief that moderate drinking is good for health

Study reveals flawed research on moderate alcohol health benefits

STUDIES suggesting that moderate alcohol consumption enhances longevity and lowers the risk of heart problems and chronic diseases compared to abstaining are based on "flawed scientific research," a new study has found.

Published over the years, these studies have led to a widespread belief that alcohol can be healthy if taken in moderation, ranging from a drink a week to two per day.


Researchers found that these studies have largely focused on moderate drinking among older adults, comparing them with 'abstainers' and 'occasional drinkers' — both groups were found to include older adults who had quit or reduced drinking due to health conditions.

"That makes people who continue to drink look much healthier by comparison," said lead researcher Tim Stockwell, a scientist with the Canadian Institute for Substance Use Research, University of Victoria.

By failing to account for people's lifetime drinking habits, these studies "suffer from fundamental design flaws," according to the authors. The findings are published in the Journal of Studies on Alcohol and Drugs.

"There is simply no completely 'safe' level of drinking," Stockwell said.

The team identified 107 published studies examining the relationship between drinking habits and longevity.

Combining all the data, it appeared that light to moderate drinkers had a 14 percent lower risk of dying during the study period compared with those abstaining from alcohol, the researchers said.

However, upon closer examination, they found that in "higher quality" studies — which analyzed drinking habits of people on average younger than 55 and ensured that former and occasional drinkers were not counted as 'abstainers' — alcohol in moderation was not linked to a longer life.

"As predicted, studies with younger cohorts and separating former and occasional drinkers from abstainers estimated similar mortality risk between low-volume drinkers and abstainers," the authors wrote.

In contrast, "lower quality" studies, involving older adults and not differentiating between former drinkers and lifelong abstainers, were the ones that linked moderate drinking with greater longevity, the authors said.

"If you look at the weakest studies, that's where you see health benefits," Stockwell said.

Due to these biases in sample selection, the studies could create misleading links between drinking and health benefits, and "can confuse communications about health risks," the authors said.

The links between moderate alcohol consumption and health benefits were first published in 1926 in a book by American biologist Raymond Pearl, called 'Alcohol and Longevity.'

In recent years, multiple studies have found that there is no such thing as a 'safe level of alcohol consumption.'

In January 2023, the World Health Organization (WHO) published a statement in The Lancet Public Health journal: "When it comes to alcohol consumption, there is no safe amount that does not affect health."

(PTI)

More For You

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
Toblerone dark chocolate discontinued in the UK, confirms Mondelez

This reflects both the popularity of the product and the frustration of fans

iStock

Toblerone dark chocolate discontinued in the UK, confirms Mondelez

Toblerone fans in the UK will no longer be able to purchase the dark chocolate version of the iconic Swiss chocolate bar, as manufacturer Mondelez has confirmed it has discontinued the product.

The company stated that it has made the “difficult decision” to stop production of the 360g Toblerone Dark bar. While no specific reason was given, Mondelez acknowledged the disappointment it may cause among consumers. A spokesperson said: “While we understand that this may be disappointing for some consumers, we continue to invest in Toblerone.”

Keep ReadingShow less
Crispello Comeback: Cadbury’s Light Treat Hits B&M Shelves

The return to UK shelves has brought a wave of nostalgia for many

Getty

Cadbury Crispello chocolate bars return to UK shelves at B&M for 49p

Cadbury's Crispello chocolate bars have made a surprise return to UK stores, now available at B&M for just 49p. The product, a mix of light wafer and smooth chocolate, had previously been discontinued in the UK and was only available overseas in recent years.

Each individual pack of Crispello contains four chocolate-covered wafer fingers, filled with a creamy chocolate centre. The sweet treat has gained attention on social media, with shoppers expressing their excitement about its reappearance in British stores.

Keep ReadingShow less
 Sharon Osbourne

Celebrities including Sharon Osbourne and Oprah Winfrey might be exhibiting signs of this side effect

Instagram/ Sharonosbourne

‘Ozempic feet’ joins growing list of unusual side effects linked to popular weight-loss drug

Ozempic, the blockbuster weight-loss medication that has surged in popularity across the United States and among celebrities, is now being linked to a new and unexpected side effect like sagging skin on the feet, informally dubbed “Ozempic feet”.

Medical experts say the condition is caused by rapid fat loss, which not only alters the appearance of the face and buttocks, but can also lead to aesthetic changes in the feet. As the drug continues to make headlines for its weight-loss benefits, concerns about such side effects are also gaining attention.

Keep ReadingShow less